Alfasigma

Alfasigma Innovative Drugs R&D Program - EIB Financing

Borrower(s)
Alfasigma
Industry
Manufacturing/Pharmaceuticals
Area of finance
Development Bank Finance
Region
Europe
Europe
Countries
Italy

Project Overview

EIB has signed a €150 million loan agreement with Alfasigma, a global pharmaceutical company founded in Italy. The financing aims to support Alfasigma’s R&D activities over the three-year period from 2025 to 2027, focusing on new treatments in gastroenterology and hepatology, vascular...

show more
Deal Volume
$166.38m
Financial Close
11/04/2025
Dealmakers

Did you work on this project?

This deal page needs more information from those involved.

Tag yourself TAG A COLLEAGUE SUGGEST AN EDIT

Tranches

To view all tranche and pricing information, login or upgrade to a subscription here